TRPV4 and hepatocellular carcinoma: Liu et al. reported that inhibiting TRPV4 in a mouse model altered the degree of single-cell polarization and significantly reduced the metastatic potential of HCC cells by impairing their adhesion to vascular endothelial cells [60].